Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Articles|April 6, 2023
Seen in the ED: Facial Pain and Swelling, Sour Mouth
Author(s)Brady Pregerson, MD
Advertisement
History of present illness. A man in his 50s presents to urgent care for 2 days of right facial swelling and pain. He denies any fever but does state he has a bad taste in his mouth.
Vital signs and physical examination. Vital signs are normal except for mild tachycardia. Examination is notable for facial swelling on the right. Dentition looks good.
Initial diagnostic testing
Labs: WBC = 14, BMP normal, CRP = 20
Imaging: CT scan is done. Two cuts are shown below.
What is the most likely diagnosis?
Advertisement
Related to this article
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement